Anti-HIV testing by automated systems.
The accuracy and ease of use of three automated test systems (Behring Opus, Boehringer Mannheim ES300 and bioMerieux Vidas) and their associated assays (Opus HIV 1 + 2, Enzymun-Test Anti-HIV 1 + 2 and Vidas HIV 1 + 2) for the detection of anti HIV-1 and anti HIV-2 in human serum and plasma were investigated by testing them against a panel of 364 well-characterised specimens. The panel included specimens confirmed to contain anti HIV-1 (n = 65) and anti HIV-2 (n = 25), specimens collected during HIV-1 seroconversion (n = 40), specimens (n = 116) which had given spurious reactions in a variety of anti-HIV screening assays, specimens from patients infected with anti HTLV-I (n = 18) and specimens from unselected blood donors (n = 100). Excluding the seroconversion specimens, all three assays were 100% sensitive. Observed specificities ranged from 98.3% to 99.6%. For the seroconversion specimens the Vidas HIV 1 + 2 was the most sensitive overall. All three assays were as sensitive and specific as most of the conventional anti-HIV enzyme immunoassays currently available. The Opus and Vidas systems would be convenient for clinical laboratories handling small to medium numbers of specimens per day. The Boehringer Mannheim ES300 is designed for larger scale use and required more familiarisation.
McAlpine
L
L
Hepatitis and Retrovirus Laboratory, Virus Reference Division Central Public Health Laboratory, Colindale, London, UK.
Parry
J V
JV
Mortimer
P P
PP